GV, the venture capital investment arm of Alphabet, led a $100m financing round for Verana Health, a technology company that is curating and analyzing real-world clinical data to advance patient care. "Verana Health is building the team and technology to unlock deep clinical insights that support the development of new treatments while increasing our understanding of how these treatments can benefit patients more broadly. Under the leadership of its strong management team, Verana continues to redefine how we approach medical research," Krishna Yeshwant, GV General Partner.